Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool October 30, 2010	Motley Fool Battle Royale Round 1: Goodyear vs. Affymax In this first-round stock matchup, the 100-year-old American superbrand Goodyear Tire & Rubber takes on Affymax.
The Motley Fool October 30, 2010	Motley Fool Battle Royale Round 1: YRC Worldwide vs. Teva Pharmaceutical In this first-round stock matchup, trucking company YRC Worldwide takes on the Israeli generic-drug giant Teva Pharmaceutical. Which stock will be left for dead on the arena floor?
The Motley Fool October 30, 2010	Motley Fool Battle Royale Final Round: Teva Pharmaceutical vs. VMware In final round, to-the-death stock match-up, the Israeli generic drug giant Teva Pharmaceutical faces VMware, a successful software firm that is turning cloud-based solutions into big business. Which stock will emerge as the ultimate victor?
The Motley Fool October 30, 2010	Motley Fool Battle Royale Round 2: VMware vs. Nordic American In this second-round stock matchup, the volatile but well-managed shipping company Nordic American Tanker Shipping takes its swings at VMware. Which stock will be crushed?
The Motley Fool October 30, 2010	Motley Fool Battle Royale Round 1: VMware vs. DryShips In this first-round stock matchup, VMware, a successful software firm that's turning cloud-based solutions into big business here on Earth, takes on DryShips, a shipping company captained by an infamously dodgy CEO. Which stock will be left for dead on the arena floor?
The Motley Fool October 30, 2010	Motley Fool Battle Royale Round 1: Nordic American vs. Hatteras Financial In this first-round stock matchup, volatile but well-managed shipping company Nordic American Tanker Shipping gets in the ring with North Carolina-based real estate investment trust Hatteras Financial, a big dividend payer. Which stock will be left for dead on the arena floor?
The Motley Fool August 5, 2004 Jeff Hwang	Goodyear, Nice Quarter Tire giant Goodyear Tire & Rubber delivers a record quarter amid accounting woes.
The Motley Fool November 16, 2011 Shubh Datta	Goodyear Tire Rolls On Goodyear Tire records a record quarter.
The Motley Fool March 29, 2004 Dave Marino-Nachison	Goodyear's Faux Rubber The tire company hopes new synthetic rubbers will help it control raw materials costs.
The Motley Fool January 19, 2010 Brian Orelli	Pfizer Gets Serious About Generics Serious, as in a potential $4-billion-purchase serious.
The Motley Fool January 10, 2012 Travis Hoium	Goodyear Tire & Rubber Shares Got Crushed: What You Need to Know Shares of Goodyear Tire & Rubber deflated a tire during a burnout today, falling 10% after a presentation to investors today.
The Motley Fool July 29, 2011 Sean Williams	Goodyear Puts the Pedal to the Metal Record revenue is nothing to ignore as this turnaround story kicks into high gear.
BusinessWeek April 19, 2004 Robert Barker	Is Goodyear's Stock Full Of Hot Air? Goodyear Tire & Rubber, after a miserable 2003 -- the stock dipped below $4 -- it's on a roll, near $9 a share. Yet it remains almost $20 below its 2002 high. Is Goodyear still a good risk?
The Motley Fool August 7, 2006 Rich Duprey	Goodyear's Burning Rubber Despite punctured profits, record sales help Goodyear beat estimates. Investors, take note.
The Motley Fool February 5, 2008 Rich Duprey	Goodyear Skids Not only has Goodyear's stock been skidding, the company was recently lapped by Japan's Bridgestone as the top wheel seller in North America.
The Motley Fool February 19, 2008 Rich Duprey	Goodyear's Good Life Pricing and premium product sales propel the tire maker to higher profits.
The Motley Fool June 18, 2004 Rich Duprey	Goodyear Retreads -- Again Goodyear Tire & Rubber once again decides to postpone releasing its earnings report.
The Motley Fool July 27, 2004 Rich Duprey	Will Goodyear Have a Good Quarter? The tire maker may report a profit when -- or if -- it announces its earnings in August.
The Motley Fool April 15, 2004 Rich Duprey	Oops! Goodyear Did It Again The tire maker ends an accounting investigation but restates its earnings.
The Motley Fool April 5, 2006 Rich Duprey	Goodyear Changes Flat Tires European operations will be pared back as the largest U.S. tire manufacturer continues to face rising raw-material and labor costs. The company -- and the stock -- still have a ways to go.
The Motley Fool November 8, 2011 Shubh Datta	Cooper Tire Run Over by High Costs Cooper Tire & Rubber reported stronger sales in its third quarter thanks to improving its product and price mix, but still saw profits nosedive.
The Motley Fool February 16, 2006 Stephen D. Simpson	Kick Tires Before Buying Goodyear has had to contend with the same kinds of cost inflation that seem to have been affecting everyone who relies upon commodity inputs. In short, this is tough stock to get excited about.
The Motley Fool February 1, 2006 Rich Duprey	Goodyear Flattened The tire maker's shares hit after announcing raw material costs were higher than expected. But with a price to free cash flow ratio of just 15, the company remains a bargain that will gain speed and traction after this bumpy strip of road.
The Motley Fool November 10, 2006 Rich Duprey	Goodyear Bridges the GAAP The tire maker's GAAP earnings show a loss, but there's more to it wrapped up in the numbers. Investors, take note.
The Motley Fool May 19, 2004 Phil Wohl	Goodyear Trying to Inflate Can the troubled tire maker pump up results and continue its turnaround?
The Motley Fool February 20, 2007 Rich Duprey	Goodyear Strikes a Loss A three month-long strike at the tire maker puts a dent in its turnaround plan. Investors, take note.
The Motley Fool April 25, 2011 Sean Williams	Pharma's Most Impervious Pipeline An investment in generics doesn't have to be a bad thing.
The Motley Fool August 8, 2005 Rich Duprey	Goodyear Gets Traction Largest U.S. tire maker doubles its profit on increases in sales and prices.
The Motley Fool May 21, 2009 Brian Orelli	If You Can't Beat 'Em, Join 'Em: Pharma Goes Generic In the battle against generic rivals, it seems pharmaceutical companies would rather switch than fight. A pair of deals heralds Big Pharma's latest moves into the generic-drug world. See what Novartis and sanofi-aventis recently did.
The Motley Fool July 27, 2005 Rich Duprey	Goodyear Getting Good Mileage An analyst upgrade sends the stock soaring, but it's not really news.
The Motley Fool January 15, 2008 Brian Orelli	Fewer Generics in Fido's Future TEVA considers selling its small animal-health business.
The Motley Fool January 3, 2005 Rich Duprey	There's No Accounting for Goodyear The world's largest tire maker delays filing annual financial reports -- again.
The Motley Fool April 7, 2010 Rick Steier	Is Teva Pharmaceutical a Forever Hold? Teva is a compelling reason why investors should look abroad for opportunity.
The Motley Fool February 24, 2005 Rich Duprey	Goodyear Expects a Good Year Tire maker's fourth-quarter earnings should complement a stellar turnaround.
The Motley Fool September 26, 2005 Rich Duprey	Goodyear Engineers Savings The largest U.S. tire maker contemplates sales of non-core businesses and closes plants. Investors apparently liked that cost-savings news and boosted Goodyear's shares some 3% last week.
The Motley Fool November 10, 2006 Rich Duprey	Goodyear's Deep Tread: Fool by Numbers Goodyear Tire & Rubber released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool September 9, 2008 Brian Orelli	Sell Dey? Perhaps Another Day Generic-drug company Mylan decides to keep its specialty pharmaceutical subsidiary.
The Motley Fool April 7, 2010 Brian Orelli	Teva: Hold Until Things Turn Ugly Despite the drugmaker's recent success, its future looks precarious.
The Motley Fool June 26, 2006 Rich Duprey	Goodyear Shreds Private-Label Brands Continuing its plan to focus on only the most profitable parts of its core business, the tire maker drops one-third of its private-label tire market. Investors, take note.
The Motley Fool February 27, 2007 Rich Duprey	Foolish Forecast: An Inflated Cooper Tire The tire maker will report its fourth-quarter 2006 financial results shortly. Investors, here is what you can expect to see.
The Motley Fool June 25, 2009 Brian Orelli	Loss of a Settlement Option Earlier this month the Federal Trade Commission came out with a report arguing for limited patent protection for drugs made by biotech companies. Now it's ratcheting up its complaints about pharmaceutical and generic-drug companies as well.
The Motley Fool August 1, 2005 Stephen D. Simpson	Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance.
The Motley Fool August 17, 2005 Rich Duprey	SEC Nails Goodyear North America's largest tire maker gets a Wells Notice over accounting issues. What will it mean to investors?
The Motley Fool April 14, 2008 Brian Orelli	Teva Gets What It Wants Teva persuades a court to order the FDA to award it a marketing exclusivity for generic Risperdal.
The Motley Fool November 9, 2007 Rich Duprey	Tire Makers Spin in Different Directions The higher cost of oil hurts both Goodyear and Cooper Tire, but one's shares rise while the other's fall. Investors, take note.
The Motley Fool February 17, 2010 Brian Orelli	This Is Not Your Generic Cash Production Teva's generating cash and knows how to use it.
The Motley Fool October 29, 2007 Rich Duprey	World's Scariest Stock: Goodyear Tire & Rubber Investors, higher oil prices are hurting this tire maker.
The Motley Fool March 5, 2008 Brian Orelli	Teva Wants the FDA to Do What? Teva wants the FDA to reinstate another drugmaker's patent.
The Motley Fool May 8, 2006 Rich Duprey	Goodyear Rolls On The tire maker reports increasing profits as it continues to slim down operations. Investors, take note.
The Motley Fool February 21, 2008 Brian Orelli	Watson Gets Less Generic Branded sales were up while generics fell for the year, which made Watson Pharmaceutical a more balanced company.